Moch H - Search Results

1

Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07.

Schraml P, von Teichman A, Mihic-Probst D, Simcock M, Ochsenbein A, Dummer R, Michielin O, Seifert B, Schläppi M, Moch H, von Moos R. Schraml P, et al. Among authors: moch h. Oncol Rep. 2012 Aug;28(2):654-8. doi: 10.3892/or.2012.1826. Epub 2012 May 18. Oncol Rep. 2012. PMID: 22614944

2

Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization.

Moch H, Schraml P, Bubendorf L, Richter J, Gasser TC, Mihatsch MJ, Sauter G. Moch H, et al. Cancer Res. 1998 Jun 1;58(11):2304-9. Cancer Res. 1998. PMID: 9622063

3

Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes.

Jiang F, Richter J, Schraml P, Bubendorf L, Gasser T, Sauter G, Mihatsch MJ, Moch H. Jiang F, et al. Among authors: moch h. Am J Pathol. 1998 Nov;153(5):1467-73. doi: 10.1016/S0002-9440(10)65734-3. Am J Pathol. 1998. PMID: 9811338 Free PMC article.

4

Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization.

Richter J, Beffa L, Wagner U, Schraml P, Gasser TC, Moch H, Mihatsch MJ, Sauter G. Richter J, et al. Among authors: moch h. Am J Pathol. 1998 Nov;153(5):1615-21. doi: 10.1016/S0002-9440(10)65750-1. Am J Pathol. 1998. PMID: 9811354 Free PMC article.

5

High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.

Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G. Moch H, et al. Am J Pathol. 1999 Apr;154(4):981-6. doi: 10.1016/S0002-9440(10)65349-7. Am J Pathol. 1999. PMID: 10233835 Free PMC article.

6

Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization.

Bissig H, Richter J, Desper R, Meier V, Schraml P, Schäffer AA, Sauter G, Mihatsch MJ, Moch H. Bissig H, et al. Among authors: moch h. Am J Pathol. 1999 Jul;155(1):267-74. doi: 10.1016/S0002-9440(10)65120-6. Am J Pathol. 1999. PMID: 10393858 Free PMC article.

7

Tissue microarrays for gene amplification surveys in many different tumor types.

Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP, Sauter G. Schraml P, et al. Among authors: moch h. Clin Cancer Res. 1999 Aug;5(8):1966-75. Clin Cancer Res. 1999. PMID: 10473073

8

Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa).

Zhao J, Richter J, Wagner U, Roth B, Schraml P, Zellweger T, Ackermann D, Schmid U, Moch H, Mihatsch MJ, Gasser TC, Sauter G. Zhao J, et al. Among authors: moch h. Cancer Res. 1999 Sep 15;59(18):4658-61. Cancer Res. 1999. PMID: 10493521

9

Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer.

Richter J, Wagner U, Schraml P, Maurer R, Alund G, Knönagel H, Moch H, Mihatsch MJ, Gasser TC, Sauter G. Richter J, et al. Among authors: moch h. Cancer Res. 1999 Nov 15;59(22):5687-91. Cancer Res. 1999. PMID: 10582685

10

Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma.

Schraml P, Müller D, Bednar R, Gasser T, Sauter G, Mihatsch MJ, Moch H. Schraml P, et al. Among authors: moch h. J Pathol. 2000 Mar;190(4):457-61. doi: 10.1002/(SICI)1096-9896(200003)190:4<457::AID-PATH551>3.0.CO;2-C. J Pathol. 2000. PMID: 10699995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters